This announcement is a separate document:
デ・ウエスタン・セラピテクス研究所：神経疼痛治療薬「DW-5LBT」再申請に向けた方針について
D. Western Therapeutics Institute: Policy regarding the re-application of the nerve pain treatment drug "DW-5LBT".
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.